NEWS

Call for grant open: apply now to attend LINNC Asia 2025!

Subdural Hematoma: Preventing Recurrence with a Three-Step Onyx Embolization

LINNC Paris 2025 – A stroke of brilliance and a celebration of innovation on Day 3

Day 2 at LINNC Paris 2025: pushing limits, refining techniques, and imagining the future of neurointervention

Linnc 2025 Day 1: navigating complexity and pushing boundaries

Philips launches intelligent 3D imaging in Europe to empower faster stro...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the CE-marking of its latest SmartCT image reconstruction solution designed to support faster, more informed decision-making in the treatment of stroke and other neurovascular conditions. Already available in Japan and Canada, SmartCT is now CE-marked and available across Europe. The solution will be showcased at LINNC Paris 2025 (June 2–4), the world’s leading interventional neuroradiology congress.  

INR Trials Book: 2025 Edition now available!

Discover this year's e-posters

The minds behind LINNC Paris: Faculty 2025

Extensive thrombus burden: Using the right material in the right situation